The report involved motor neuropathy in a participant of the phase 2 trial conducted outside the U.S., according to an Oct. 16 news release from the company. The participant received the vaccine in ...

A strain of influenza appears to have disappeared from the planet since COVID. As a result, U.S. flu vaccines have been ...

Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its ...

Multiple users on social media share that the Apple Watch detected something was "off" days before they themselves knew they ...

Respiratory virus season is underway, but Washington is more prepared than it was last year to protect against some severe ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

Disruptions from Hurricane Helene exacerbated shortages of critical intravenous fluids in the United States, and now the ...

The Food and Drug Administration put clinical holds on Novavax's COVID-19 and flu combination vaccine and its standalone flu ...

The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on hold after ...

The hold, which was made in response to a serious adverse event report, could impact the company’s plans to start a Phase 3 trial of a combination shot for COVID-19 and influenza.

Sirish Subash is named "America's Top Young Scientist" for his device PestiSCAND that can help detect harmful pesticide ...

The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.